Canadian Government Partners with OmniaBio to Expand Facility at McMaster Innovation Park
Hamilton Business Review
“The Government of Canada is working tirelessly to build up Canada’s life sciences and biomanufacturing sector to develop safe and effective next-generation treatments. Since March 2020, over $2.3 billion has been invested to rebuild Canada’s vaccines, therapeutics and biomanufacturing capacity across our country.
Today, the Honourable Anita Anand, Minister of Innovation, Science and Industry, announced that Canada will work with OmniaBio to expand its facility to manufacture cell and gene therapies and provide production services to companies around the world, strengthening Canada’s participation in global value chains. Cell and gene therapies have the potential to revolutionize the treatment of a broad range of life-threatening diseases.
OmniaBio’s project will be focusing primarily on advanced treatments for chronic diseases, including cancer, autoimmune conditions, diabetes, and cardiovascular and neurological diseases. OmniaBio is seeking to expand its current space at the McMaster Innovation Park facility in Hamilton, Ontario, and invest in artificial intelligence- and robotics-enabled clinical and commercial scale manufacturing.”
See what's possible. Bring your discovery to market.
Related Articles
Related
Powering the Future
AP Renewables’ new tool helps out the little guyAmin Ahmadi wants you to imagine that you own a fleet of cars. It’s the metaphor that he feels best describes the challenges facing wind farm operators today. And if that seems like a bit of a stretch, hear him out.“Cars...
McMaster and Local Hospitals Personalize Cancer Treatment
"'The Juravinski Research Institute (JRI) is supporting a groundbreaking project by Hamilton Health Sciences, McMaster University and St. Joseph’s Healthcare Hamilton that could transform cancer treatment in Hamilton and serve as a model for cancer care across...
McMaster PhD Student Uses AI to Predict Fractures
"Could AI be used to assess fracture risk for older adults? That’s the question at the heart of research being done by PhD student Edward Chu, who is exploring how machine learning could predict fractures in older adults with osteoporosis. Currently, when health-care...